EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
   1.1.1.105 | Blindness |
19686838 |
Retinol dehydrogenase 12 detoxifies 4-hydroxynonenal in photoreceptor cells. |
therapeutic application
unassigned |
1
0 |
| 1.1.1.105 | Leber Congenital Amaurosis |
19686838 |
Retinol dehydrogenase 12 detoxifies 4-hydroxynonenal in photoreceptor cells. |
therapeutic application
unassigned |
1
0 |
| 1.1.1.105 | Retinal Dystrophies |
19686838 |
Retinol dehydrogenase 12 detoxifies 4-hydroxynonenal in photoreceptor cells. |
therapeutic application
unassigned |
1
0 |
| 1.1.1.105 | Glioma |
29285249 |
Retinol dehydrogenase-10 promotes development and progression of human glioma via the TWEAK-NF-?B axis. |
causal interaction
ongoing research
unassigned |
3
1
0 |
| 1.1.1.105 | Neoplasms |
29285249 |
Retinol dehydrogenase-10 promotes development and progression of human glioma via the TWEAK-NF-?B axis. |
causal interaction
ongoing research
unassigned |
3
1
0 |
| 1.1.1.105 | all-trans-retinol dehydrogenase (nad+) deficiency |
27740873 |
Retinol Dehydrogenase-10 Regulates Pancreas Organogenesis and Endocrine Cell Differentiation via Paracrine Retinoic Acid Signaling. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
| 1.1.1.105 | Blindness |
18326732 |
Retinol dehydrogenases RDH11 and RDH12 in the mouse retina: expression levels during development and regulation by oxidative stress. |
causal interaction
unassigned |
3
0 |
| 1.1.1.105 | Leber Congenital Amaurosis |
18326732 |
Retinol dehydrogenases RDH11 and RDH12 in the mouse retina: expression levels during development and regulation by oxidative stress. |
causal interaction
unassigned |
3
0 |
| 1.1.1.105 | Retinal Dystrophies |
18326732 |
Retinol dehydrogenases RDH11 and RDH12 in the mouse retina: expression levels during development and regulation by oxidative stress. |
causal interaction
unassigned |
3
0 |
| 1.1.1.105 | Febrile Neutropenia |
11584902 |
Retrospective review of febrile neutropenia in the Royal Darwin Hospital, 1994-99. |
therapeutic application
unassigned |
4
0 |
